CD69 and myeloid sarcoma: Both CD20dim and CD69+ versus CD20− and CD69− CD8+ memory T cells, which were localized in the MS CSF, were enriched for the RUNX3+EOMES+T-bet− profile (p < 0.0001 and p < 0.05; Figure 3E,F).